Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Condition(s):LeukemiaLast Updated:June 21, 2013Completed
Hide Studies Not Open or Pending
Condition(s):LeukemiaLast Updated:June 21, 2013Completed
Condition(s):Leukemia; Neutropenia; ThrombocytopeniaLast Updated:March 6, 2015Completed
Condition(s):Leukemia; LymphomaLast Updated:June 20, 2013Completed
Condition(s):Leukemia; LymphomaLast Updated:July 4, 2016Completed
Condition(s):Leukemia; LymphomaLast Updated:August 21, 2013Completed
Condition(s):Leukemia; LymphomaLast Updated:August 21, 2023Completed
Condition(s):Leukemia; LymphomaLast Updated:September 17, 2018Completed
Condition(s):Leukemia; LymphomaLast Updated:December 19, 2013Completed
Condition(s):Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic SyndromesLast Updated:October 26, 2018Completed
Condition(s):Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unusual Cancers of ChildhoodLast Updated:September 27, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.